Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
about
Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies.Autophagy and apoptosis: studies on the effects of bisthiosemicarbazone copper(ii) complexes on p53 and p53-null tumour cell lines.Hypoxia and antitumor CD8+ T cells: An incompatible alliance?Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy.Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy.Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning.Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine.Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts.CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion.Hypoxia and acidosis: immune suppressors and therapeutic targets.Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer.Current status and future directions of cancer immunotherapy.Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment.Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
P2860
Q36190013-70B2C832-16C5-475A-A013-86E2B8EDDBB2Q38731169-4A6EC939-2B94-4C52-9327-448F7CD0A1BFQ38998450-C1C61B61-5190-4DC7-BB6E-EEA64F2CC155Q39110234-156D3518-42BC-40CD-B85D-57A78EC26F00Q47726467-97F1B16B-FFA9-4905-8CBB-6A1D392B7818Q49283462-F3B89139-B276-4719-AEC9-125B990A2F68Q49679692-2690AAEB-C608-41E2-8ED5-822134190A19Q50042918-FB0D6465-9E36-45F6-B09F-2106300F5F92Q52353619-BFB6EA5E-216C-4F3F-B0C4-D30B76656CA9Q52617702-4BD7DFB2-0F78-4C71-9F96-06B465FDDAA0Q52683574-FD5E5E4C-CFF8-40C8-92F1-327007ABFEF4Q54976476-B052E75B-883B-4022-8CF9-5BCFB149680AQ55070491-E3C1CAC2-8304-47B2-9DCE-CD7305A1CD69Q55080593-B04AF8C9-4053-45CA-B1D9-396EA1CA0D9BQ55240544-65FE68FA-9E14-4194-950B-EB1015CE7B1BQ56889832-634B0BAC-6612-4447-B61C-38C8B8DD6C4F
P2860
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
@en
type
label
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
@en
prefLabel
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
@en
P2093
P2860
P356
P1433
P1476
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
@en
P2093
K Kosmatopoulos
P2860
P2888
P304
P356
10.1038/ONC.2016.225
P407
P577
2016-06-27T00:00:00Z
P6179
1009264551